META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS

被引：0
|
作者：
Chirila, C. [1 ]
Odom, D. M. [1 ]
Devercelli, G. [2 ]
Khan, S. [3 ]
Sherif, B. N. [1 ]
Kaye, J. A. [4 ]
Molnar, I. [5 ]
Sherrill, B. H. [1 ]
机构：
[1] RTI Hlth Solut, Biometr, Res Triangle Pk, NC USA
[2] Bayer HealthCare, Global Hlth Econ & Outcomes Reasearch, Montville, NJ USA
[3] RTI Hlth Solut, Regular & Hlth Outcomes, Res Triangle Pk, NC USA
[4] RTI Hlth Solut, Epidemiol, Res Triangle Pk, NC USA
[5] Bayer HealthCare, Global Med Affairs, Montville, NJ USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [41] Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
    Run-Cong Nie
    Xue-Bin Zou
    Shu-Qiang Yuan
    Ying-Bo Chen
    Shi Chen
    Yong-Ming Chen
    Guo-Ming Chen
    Xiao-Jiang Chen
    Tian-Qi Luo
    Shu-Man Li
    Jin-Ling Duan
    Yun Wang
    Yuan-Fang Li
    [J]. BMC Cancer, 20
  • [42] Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
    Nie, Run-Cong
    Zou, Xue-Bin
    Yuan, Shu-Qiang
    Chen, Ying-Bo
    Chen, Shi
    Chen, Yong-Ming
    Chen, Guo-Ming
    Chen, Xiao-Jiang
    Luo, Tian-Qi
    Li, Shu-Man
    Duan, Jin-Ling
    Wang, Yun
    Li, Yuan-Fang
    [J]. BMC CANCER, 2020, 20 (01)
  • [43] APPLICATION OF PROGRESSION-FREE SURVIVAL AS SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN NICE REVIEWS OF ADVANCED BREAST CANCER DRUGS
    Zou, D.
    Sun, A.
    Musci, R.
    Milev, S.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S183 - S184
  • [44] Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials
    Woodford, Rachel
    Zhou, Deborah
    Kok, Peey-Sei
    Lord, Sally J.
    Friedlander, Michael
    Marschner, Ian
    Simes, R. John
    Lee, Chee Khoon
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [45] Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
    Dimopoulos M.
    Sonneveld P.
    Manier S.
    Lam A.
    Roccia T.
    Schecter J.M.
    Cost P.
    Pacaud L.
    Poirier A.
    Tremblay G.
    Lan T.
    Valluri S.
    Kumar S.
    [J]. BMC Cancer, 24 (1)
  • [46] PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Dimopoulos, M.
    Sonneveld, P.
    Nahi, H.
    Kumar, S.
    Hashim, M.
    Kulakova, M.
    Duran, M.
    Heeg, B.
    Lam, A.
    Dearden, L.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A408 - A408
  • [47] META-ANALYSIS OF PROGRESSION-FREE SURVIVAL IMPACT OF BIOLOGICAL THERAPY IN RELAPSED METASTATIC COLORECTAL CANCER
    Chan, David
    Segelov, Eva
    Shapiro, Jeremy
    Price, Timothy J.
    Karapetis, Christos S.
    Tebbutt, Niall
    Pavlakis, Nick
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 117 - 117
  • [48] The validity of progression-free survival 2 as a surrogate trial end point for overall survival
    Woodford, Rachel G.
    Zhou, Deborah D. X.
    Kok, Peey-Sei
    Lord, Sally J.
    Friedlander, Michael
    Marschner, Ian C.
    Simes, R. John
    Lee, Chee Khoon
    [J]. CANCER, 2022, 128 (07) : 1449 - 1457
  • [49] The validity of progression-free survival (PFS) 2 as a surrogate endpoint for overall survival (OS) in randomized controlled trials (RCTs) of advanced solid tumors.
    Woodford, Rachel
    Zhou, Deborah
    Kok, Peey-Sei
    Lord, Sally
    Marschner, Ian
    Friedlander, Michael
    Lee, Chee Khoon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Estimating changes in overall survival using progression-free survival in metastatic breast and colorectal cancer
    Bowater, Russell J.
    Lilford, Philippa E.
    Lilford, Richard J.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (03) : 207 - 214
12345